Literature DB >> 31527765

Brolucizumab: is extended VEGF suppression on the horizon?

Ashish Sharma1, Nilesh Kumar2, Baruch D Kuppermann3, Anat Loewenstein4, Francesco Bandello5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31527765      PMCID： PMC7055597          DOI： 10.1038/s41433-019-0582-0

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

1.  Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates.

Authors:  Szilárd Kiss; Kristina Oresic Bender; Ruslan N Grishanin; Kelly M Hanna; Julio D Nieves; Pallavi Sharma; Aivan T Nguyen; Romeo J Rosario; Judith S Greengard; Claire M Gelfman; Mehdi Gasmi
Journal:  Transl Vis Sci Technol       Date:  2021-01-29       Impact factor: 3.283
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.